Search the Newsreel

Carlyle Secured Lending Inc (CGBD) Earnings Forecast: Future EPS & Revenue Growth Estimates

5 Must-Read Analyst Questions From Carlyle’s Q2 Earnings Call

5 Must-Read Analyst Questions From Carlyle's Q2 Earnings Call Carlyle's second quarter saw results that met expectations, with the company delivering improved revenue and profitability driven by strong performance in its AlpInvest and Global Credit divisions. Management attributed this growth to disciplined execution, record …

Why Darling Ingredients (DAR) Is Up 5.1% After Earnings Rebound And Enlarged Buyback Program

Darling Ingredients Inc. (DAR) saw its stock rise 5.1% after reporting strong second-quarter and year-to-date results and increasing its share repurchase authorization to a total of US$1.00 billion. The company has already repurchased a significant number of shares since 2015, indicating a commitment to …

Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages

Charles River Laboratories International (NYSE:CRL) has received an average "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $255.65. This follows the company exceeding quarterly earnings expectations with an adjusted EPS of $3.02 and revenue of $1.0 billion. Despite recent …

Darling Ingredients Jumps 5.5% Amid Sector-Wide Rally

Darling Ingredients Inc. (DAR) surged 5.5% amidst a sector-wide rally, with its stock closing at $62.69. This movement was mirrored by other packaged foods companies like Archer-Daniels-Midland (ADM) and Bunge (BG), suggesting a broader positive sentiment in the market rather than a company-specific catalyst. …

Is Soft Core Demand and Cash Flow Pressure Reshaping Harley-Davidson’s Brand-First Strategy (HOG)?

Schwab chief risk officer Nigel Murtagh sells $2.9m in stock

Nigel J. Murtagh, Chief Risk Officer at Charles Schwab Corp., recently sold approximately $2.9 million worth of company stock through a pre-arranged trading plan. These sales followed his exercise of nonqualified stock options totaling over $1.2 million, after which he retains a significant holding …

Charles Schwab: Chief Risk Officer verkauft Aktien im Wert von 2,9 Mio. US-Dollar

Charles Schwab (NYSE:SCHW) Director Sells 5,263 Shares of Stock

Charles Schwab (NYSE:SCHW) Director Paula Sneed sold 5,263 shares of the company's stock for approximately $563,930 on August 7th, reducing her position by 5.43%. Following the sale, she retained 91,711 shares. The company recently reported strong quarterly earnings, exceeding analyst estimates, and declared a …

Nigel Murtagh Sells 24,778 Shares of Charles Schwab (NYSE:SCHW) Stock

Charles Schwab insider Nigel Murtagh sold 24,778 shares of company stock for approximately $2.70 million. This transaction reduced his ownership by nearly 30% and was conducted under a pre-arranged Rule 10b5-1 plan. Despite the insider sale, Charles Schwab reported strong quarterly earnings, beating analyst …

SCHWAB CHARLES CORP (SCHW) insider Charles R. Schwab gifts 37,200 shares via trust

Charles R. Schwab, Co-Chairman of SCHWAB CHARLES CORP (SCHW), reported a bona fide gift transfer of 37,200 common stock shares on August 6, 2026. This transaction, made indirectly through a Trust, reflects his resignation as trustee of two trusts benefiting relatives. Following the gift, …

Schwab director Paula Sneed sells $563,954 in common stock By Investing.com

Paula A Sneed, a director at Charles Schwab Corp. (NYSE:SCHW), recently sold 5,263 shares of company stock for approximately $563,954. The sale occurred in multiple trades with prices ranging from $107.07 to $107.205 per share, as Schwab's stock trades near its 52-week high. Following …

Charles Schwab (SCHW) risk chief sells 26,675 shares after option exercise

Nigel J. Murtagh, Chief Risk Officer at Charles Schwab, exercised nonqualified stock options for 26,675 shares at $46.81 per share and subsequently sold them at an average of $109 per share on August 6 and 10, 2026. These transactions, which generated an approximate pre-tax …

ALBEMARLE AKTIE: AI-Analysen, Prognose & Kursziel

Insider Selling: Darling Ingredients (NYSE:DAR) EVP Sells $100,312.55 in Stock

Darling Ingredients (NYSE:DAR) Executive Vice President Nicholas James Kemphaus recently sold 1,591 shares of the company's stock for a total of $100,312.55, reducing his ownership by 4.34%. This transaction follows a strong quarterly performance where Darling Ingredients beat earnings estimates, with revenue increasing 16.4% …

Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …

Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …

Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options

Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …

James Foster (CRL) files Form 144 for 28,733-share option sale

James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …

Charles River (CRL) EVP Victoria Creamer exercises options and sells 4,179 shares

Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …

Darling Ingredients (DAR) insider plans Rule 144 sale of 1,591 shares

Darling Ingredients Inc. has filed a Rule 144 notice for an insider to sell 1,591 shares of common stock through Charles Schwab & Co., Inc. The aggregate market value of these shares is $100,312.55, and they are listed on the NYSE. The filing also …

Schwab Trading Activity Index up modestly in July (SCHW:NYSE)

The Charles Schwab Corporation's trading activity index (STAX) showed a modest increase in July, rising to 59.80 from 59.12 in June. Schwab clients were net buyers of ETFs and equities at a two-to-one ratio, indicating continued bullish sentiment among self-directed traders.

Carlisle Companies Incorporated (CSL) Stock Price, News, Quote & History

This page provides comprehensive financial information for Carlisle Companies Incorporated (CSL), including its current stock price, recent news, historical data, and analyst insights. It details the company's operations in building envelope products through its Carlisle Construction Materials and Carlisle Weatherproofing Technologies segments. The stock …

Carlyle Group Inc. Q2 2026: Revenue $1123.5M, EPS $0.37— 10-Q Summary

Carlyle Group Inc. reported its Q2 2026 financial results, with revenue reaching $1123.5M and diluted earnings per share at $0.37, significantly lower than the previous year. Despite a decrease in net income and revenue, the company saw modest growth in management fees and an …

Linqto Continues to Pursue Litigation Against Forge and Schwab to Recover Millions of Dollars in Damages to More than 13,000 Linqto Customers

Company Also Moving Forward With Risk Mitigation Strategies to Exit Bankruptcy as Quickly as Possible SAN JOSE, Calif. & HOUSTON, August 10, 2026--(BUSINESS WIRE)--Linqto, Inc. today announced that it continues to pursue its litigation against Forge Global, Inc. and its owner, The Charles Schwab …

Arlo Technologies (NYSE:ARLO) Shares Down 7.9% - Here's Why

Arlo Technologies (NYSE:ARLO) saw its shares drop 7.9% during mid-day trading despite exceeding quarterly earnings and revenue expectations. The company reported $0.28 EPS against an expected $0.20 and $155.94 million in revenue against $148.94 million, with revenue up 20.5% year-over-year. Analyst sentiment remains largely …

Schwab Clients Buy Late-July Dips Across Stocks, ETFs and Options

The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from June's 59.12, indicating that Schwab clients were net buyers during late-month market dips. Gen X clients and self-directed traders showed the strongest buying interest, focusing on individual stocks, ETFs, and …

Schwab Trading Activity Index™: STAX Score Increases Modestly in July

Schwab Trading Activity Index vs. S&P 500 (Graphic: Charles Schwab) Schwab clients were net buyers, using late-month dips to add exposure across individual stocks, ETFs, and options Key Takeaways: The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from its …

Carlyle Group heavily invested in medical supplies giant Medline (MDLN.US) and aviation maintenance giant StandardAero (SARO.US) in Q2, and established a position in AI cloud service provider Nebius (NBIS.US).

Carlyle Group's Q2 2026 13F filing shows a total holdings market value of $10 billion, a slight decrease from the previous quarter. The group heavily invested in medical supplies giant Medline (MDLN.US) and aviation maintenance giant StandardAero (SARO.US), which remain its top two holdings, …

Ardea Resources (ASX:ARL) Climbs As Goongarrie Nickel Study Stays In Focus

International Markets and Charles River (CRL): A Deep Dive for Investors

Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this medical research equipment and services provider, examining the trends in international revenues is essential for assessing its financial resilience and …

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …

The Cheapest Harley-Davidson That Still Feels Properly American

Harley-Davidson has introduced the 2026 Deadwood, a factory bobber designed to evoke the raw, stripped-down aesthetic of postwar American motorcycles. Priced at $17,999, it's $2,000 less than the Heritage Classic it's based on, offering a powerful Milwaukee-Eight 117 engine and modern electronics beneath its …

TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating

TD Cowen has increased its price target for Charles River Laboratories International (CRL) to $300 from $235, while reiterating a Buy rating on the stock. This adjustment comes amidst other analyst updates for the company, indicating positive sentiment following recent financial announcements. The article …

Harley-Davidson (NYSE:HOG) Delivers Dividend Quality with Consistency and Solid Fundamentals

ALBEMARLE CORPORATION : MORGAN STANLEY CUTS TARGET PRICE TO $161.00 FROM $189.00

Morgan Stanley has adjusted its target price for Albemarle Corporation (ALB), reducing it to $161.00 from the previous $189.00. This update indicates a revised outlook from the investment bank regarding the company's valuation. The report was issued by Reuters.